Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance

Boston Scientific CorporationTrade
Vanguard Total Stock Market Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Boston Scientific Corporation trades at $51.28 (market cap $74.19B), while Vanguard Total Stock Market Index Fund ETF trades at $381.8. The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.

BSXVTI
Market Cap
$74.19B
Sector
Health
52-Week High
$108.14$381.78
52-Week Low
$42.63$311.68
Enterprise Value
$86.27B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

Boston Scientific (BSX) trades at $51.66, up 2.38% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains bullish technical signals with moving averages supporting upward movement, though oscillators indicate potential overbought conditions. Fundamentally, BSX demonstrates robust growth with 2025 revenue reaching $20.07B and net income margin expanding to 14.43%, supported by strong cash flow generation of $1.54B in 2025.

The outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target offering 30% upside potential. Key risks include competitive pressures in WATCHMAN and electrophysiology segments, along with recent guidance cuts. Insider buying by the CEO and director signals management confidence in the company's long-term prospects despite near-term challenges.

Vanguard Total Stock Market Index Fund ETF

VTI trades at $381.83, up 0.05% with a bullish technical signal from moving averages and strong institutional inflows. The ETF's 0.03% expense ratio and over 3,500 holdings provide broad U.S. equity exposure. Recent dividend of $1.04 was declared for June 2026.

Outlook remains positive due to low-cost diversification and steady institutional demand. Risks include market volatility and concentration in large-cap tech. Long-term growth potential is supported by historical performance but requires monitoring of economic conditions.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Vanguard Total Stock Market Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

Read more on VTI